All Comments by

  1. Jean-François Foncin on San Diego: What—3 Percent? Money Woes Trump Science at SfN
  2. René Spiegel on London: What Regulators Say About Trials in Familial AD
  3. David Gillam on Focus on the Locus! (Ceruleus, That Is, in Alzheimer’s Disease)
  4. Lary Walker on San Diego: TDP-43 Targets Loom Large—But Where’s the Bull’s Eye?
  5. Steven Brenner on Focus on the Locus! (Ceruleus, That Is, in Alzheimer’s Disease)
  6. Steven Brenner on San Diego: ALS Research Goes to the Dogs
  7. Robert Vassar on Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes.
  8. Elizabeth Heilig on Mutation analysis of the presenilin 1 N-terminal domain reveals a broad spectrum of gamma-secretase activity toward amyloid precursor protein and other substrates.
  9. Hans-Ulrich Demuth on Identification of low molecular weight pyroglutamate A{beta} oligomers in Alzheimer disease: a novel tool for therapy and diagnosis.
  10. Kiumars Lalezarzadeh on The AD8—Dementia Screen Ready for Prime Time?
  11. Sam Gandy on Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma.
  12. Mikko Laakso on Indianapolis: Neuroimaging Opens Window to Disease, Better Diagnosis
  13. James Galvin on The AD8—Dementia Screen Ready for Prime Time?
  14. Gilbert J. Ho on A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain.
  15. Emory Hill on The AD8—Dementia Screen Ready for Prime Time?